Clinical Study

Cysticerci Drive Dendritic Cells to Promote In Vitro and In Vivo Tregs Differentiation

Table 1

Levels of cytokines in supernatants from in vitro DC differentiation and in vitro regulatory T cell induction.

IFN- TNF- IL-10IL-6IL-2TGF-

DC nonstimulated0.39 ± 0.883.98 ± 3.823.17 ± 1.79>50000.34 ± 0.77406.50 ± 191.69
Control medium 10% HSAB3.55 ± 0.515.78 ± 1.795.12 ± 1.50>5000 1.59 ± 1.41ND
  differentiation in the presence of
 Dexamethasone03.12 ± 0.4730.84 ± 5.82a>50000545.17 ± 289.37
Taenia crassiceps 0.78 ± 1.752.98 ± 1.753.77 ± 1.76>50000.72 ± 0.98341.50 ± 238.19
Taenia solium 04.58 ± 4.447.31 ± 4.88>50000436.00 ± 243.95
Treg induction from naïve CD4+  cells
 DC nonstimulated, nonpulsed (Ag) 0.76 ± 1.311.21 ± 1.070.99 ± 0.932.58 ± 0.700.45 ± 0.78124.60 ± 5.35
 DC nonstimulated pulsed (Ag+) 0.78 ± 1.752.06 ± 0.881.22 ± 1.122.78 ± 0.600.43 ± 0.9593.07 ± 16.98
 Dexamethasone nonpulsed (Ag) 0.63 ± 1.261.68 ± 0.341.01 ± 1.182.97 ± 2.020.39 ± 0.7895.49 ± 19.66
 Dexamethasone pulsed (Ag+) 1.00 ± 1.742.49 ± 0.362.32 ± 1.362.78 ± 1.101.38 ± 1.2798.63 ± 26.39
T. crassiceps nonpulsed (Ag) 1.23 ± 2.132.09 ± 0.791.02 ± 1.768.15 ± 1.261.31 ± 1.2199.22 ± 31.64
T. crassiceps pulsed (Ag+) 1.26 ± 1.812.18 ± 0.381.44 ± 0.8129.34 ± 46.750.43 ± 0.95119.80 ± 42.56
T. solium nonpulsed (Ag) 4.50 ± 2.612.35 ± 0.681.48 ± 2.1056.99 ± 5.2112.14 ± 11.79111.00 ± 3.54
T. solium pulsed (Ag+) 1.73 ± 2.452.28 ± 0.681.95 ± 0.0911.68 ± 6.026.61 ± 6.1678.50 ± 21.21
 Control T cell1.54 ± 1.411.90 ± 0.481.77 ± 0.992.01 ± 0.450.88 ± 1.20101.00 ± 16.58

Significantly different ( ) compared to nonstimulated DC.   AB sera from healthy donors were used in DC differentiation experiments. Levels of cytokines in the control medium supplemented with 10% HSAB are shown.